Form D · Pharmaceuticals
Grace Therapeutics, Inc.
Princeton, NJ · CIK 0001444192
Offering snapshot reported Aug 11, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Aug 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2026 | Initial | $9,999,998 | No comparison | 9 | SEC filing |
| Feb 25, 2025 | Initial | $14,999,985 | No comparison | 14 | SEC filing |
| Oct 10, 2023 | Initial | $7,499,793 | No comparison | 4 | SEC filing |
| May 25, 2018 | Initial | $372,637 | No comparison | 1 | SEC filing |
| Sep 2, 2011 | Initial | $170,466 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $560K
- Finders' fees
- $0
- Form D file number
- 021-593703
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Craig-Hallum Capital Group | 000121395 |
Source: Form D, filed Aug 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jean Marie (John) Canan | Director |
| Roderick N. Carter | Director |
| Michel Chartrand | Director |
| Janelle D'alvise | Director, Executive |
| Carrie D'andrea | Executive |
| A. Brian Davis | Director |
| A. Brian Davis | Director |
| Robert J. Del Aversano | Executive |
| Robert J. Del Aversano | Executive |
| Ronald Denis | Director |
| Michael Derby | Director |
| Brian Ford | Executive |
| Martin Godbout | Director |
| Xavier Harland | Executive |
| Henri Harland | Director, Executive |
| Vimal Kavuru | Director |
| Prashant Kohli | Director, Executive |
| S. George Kottayil | Director |
| S. George Kottayil | Director |
| Amresh Kumar | Executive |
| Marc Lebel | Director |
| Dr. R. Loch Macdonald | Executive |
| Dr. R. Loch Macdonald | Executive |
| Edward Neugeboren | Director |
| Linda P. O'keefe | Executive |
| Donald Olds | Director |
| Tina Sampalis | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
103 Carnegie Center Suite 300
Princeton, NJ, 08540
Princeton, NJ, 08540